Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:28:50.409Z.
Calculation as of: 2026-10-06T21:28:50.409Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87d00981f6afc2d6fb42b8babadf75d30967326f42a5e12d4c63051d6ceded83
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Atrium Therapeutics, Inc.
Market Cap
$136.67M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.57M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.80M
Free Cash Flow Yield
0.19%
TTM Avg
0.11%
3Y Avg
0.11%
5Y Avg
0.11%
Market Cap
$139.04M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.84M
Free Cash Flow Yield
N/A
TTM Avg
3.59%
3Y Avg
3.59%
5Y Avg
3.59%
Market Cap
$131.21M
Free Cash Flow Yield
0.58%
TTM Avg
1.43%
3Y Avg
2.33%
5Y Avg
2.75%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.67M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 0.19% | 0.11% | 0.11% | 0.11% |
| Immuneering Corporation (IMRX)vs › | $139.04M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | N/A | 3.59% | 3.59% | 3.59% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 2.89% | 2.51% | 2.47% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.58% | 1.43% | 2.33% | 2.75% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 9.99% | 8.24% | 8.24% | 8.24% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
